z-logo
open-access-imgOpen Access
Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report
Author(s) -
Vladimir Neychev,
Samira M. Sadowski,
Jinfang Zhu,
Michael Allgäeuer,
Katja Kilian,
Paul S. Meltzer,
Electron Kebebew
Publication year - 2015
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2015-3684
Subject(s) - cowden syndrome , pancreas , medicine , neuroendocrine tumors , pathology , pten , biology , apoptosis , pi3k/akt/mtor pathway , biochemistry
Germline mutations in the phosphatase and tensin homolog (PTEN) tumor suppressor gene are found in the majority of patients with Cowden syndrome (CS), who have an increased risk of breast, thyroid, and endometrial cancer. According to our current understanding of genetic changes in the PTEN gene and the resultant phenotypic features of CS, pancreatic neuroendocrine tumors (NETs) are not considered part of the clinical spectrum of CS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom